Tuesday, October 21, 2014

Top 5 Information Technology Stocks To Watch Right Now

With shares of International Business Machines (NYSE:IBM) trading around $178, is IBM an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

IBM is an information technology company. The company operates in five segments: Global Technology Services, Global Business Services, Software, Systems and Technology, and Global Financing. Technology products and services are in high demand worldwide as consumers want to be up-to-speed, and companies always need the latest and greatest to stay ahead of the competition. Cloud computing has been hot in recent times, which has not been good news for IBM. Should the company want to hold on to its market share, it needs to make moves quickly, and provide the technology products and services that worldwide consumers and companies demand.

IBM is swiveling to win over a new market in the competition — India — and attacking Amazon (NASDAQ:AMZN) via ads is a major strategy, according to the Economic Times. Amazon�� new effort in India comes in the wake of a losing a federal contract worth $600 million to Amazon. The contract was with the Central Intelligence Agency. IBM contested the contract in court, trying to claim it for itself ��but the court ruled that the contract remain with Amazon.

Hot Forestry Stocks To Invest In Right Now: Trico Bancshares (TCBK)

TriCo Bancshares (TriCo), incorporated on October 13, 1981, is a bank holding company that operates through its wholly owned subsidiary, Tri Counties Bank (the Bank). The Bank conducts a commercial banking business, including accepting demand, savings and time deposits, and making commercial, real estate and consumer loans. It also offers installment note collection, issues cashier's checks, sells travelers checks, and provides safe deposit boxes and other customary banking services. Brokerage services are provided at the Bank's offices by the Bank's association with Raymond James Financial Services, Inc., an independent financial services provider and broker-dealer. The Bank does not offer trust services or international banking services. Tri Counties Bank, TriCo Capital Trust I and TriCo Capital Trust II are the subsidiaries of the Bank. On September 23, 2011, the Bank acquired Bank of Northern California.

The Company is engaged in the banking business through 68 offices in 23 counties in Northern and Central California including ten offices in Shasta County, nine in Butte County, seven in Sacramento and Nevada Counties, six in Placer County, four in Stanislaus County, three each in Siskiyou, Sutter and Kern Counties, two each in Glenn and Yolo Counties, and one each in Contra Costa, Del Norte, Fresno, Lake, Lassen, Madera, Mendocino, Merced, Napa, Tehama, Tulare, and Yuba Counties. The Bank�� 76 automated teller machines (ATMs) are linked to several national and regional networks, such as CIRRUS and STAR. In addition, banking by telephone on a around-the-clock toll-free number is available to all customers. This service allows a customer to obtain account balances and most recent transactions, transfer moneys between accounts, make loan payments and obtain interest rate information. The Bank emphasizes on retail banking. Most of the Bank's customers are retail customers and small to medium-sized businesses. The Bank emphasizes serving the needs of local businesses, farmers and ranche! rs, retired individuals and wage earners.

Lending activities

The Bank conducts a commercial banking business, including accepting demand, savings and time deposits and making commercial, real estate, and consumer loans. It also offers installment note collection, issues cashier�� checks, sells travelers checks and provides safe deposit boxes and other customary banking services. Brokerage services are provided at the Bank�� offices by the Bank�� association with Raymond James Financial Services, Inc., an independent financial services provider and broker-dealer. The Bank concentrates its lending activities in four principal areas: real estate mortgage loans (residential and commercial loans), consumer loans, commercial loans (including agricultural loans), and real estate construction loans. The majority of the Bank�� loans are direct loans made to individuals, farmers and local businesses.

As of December 31, 2011 loans, including net deferred loan costs, totaled $1,551,032,000. As of December 31, 2011, total Real estate mortgage loans net deferred loan costs, were $ 965,922,000; total consumer loans were $ 406,330,000; total commercial loans were $ 139,131,000, and real estate construction loans were $ 39,649.

Investment Activities

The Bank classifies its investments as available for sale (AFS). As of December 31, 2011, investments consisted of corporate debt and debt securities of the United States government. As of December 31, 2011, the Bank�� securities portfolio consisted of obligations of the United States Government corporations and agencies, obligations of states and political subdivisions, and corporate bonds.

Sources of Funds

Most of the Bank's deposits are attracted from individuals and business-related sources. The various types of deposits offered by the Bank include non-interest-bearing demand deposits, interest-bearing demand deposits, savings deposits, time certificates of $100,000 and o! ver, and ! other time certificates. As of December 31, 2011, the Bank�� deposits totaled $ 2,190,536. The Bank participates in a deposit program offered by the State of California whereby the State may make deposits at the Bank�� request subject to collateral and creditworthiness constraints.

The Company had $8,527,000 of other collateralized borrowings as of December 31, 2011. The Company maintains a collateralized line of credit with the Federal Home Loan Bank of San Francisco. Other collateralized borrowings are generally overnight maturity borrowings from non-financial institutions that are collateralized by securities owned by the Company. The Bank had available unused correspondent banking lines of credit from commercial banks totaling $5,000,000 for federal funds transactions as of December 31, 2011.

Advisors' Opinion:
  • [By Rich Duprey]

    California-based�TriCo Bancshares (NASDAQ: TCBK  ) announced today its second-quarter dividend of $0.11 per share, a 22% increase over the $0.09 per share payout it made last quarter.

Top 5 Information Technology Stocks To Watch Right Now: ImmunoGen Inc.(IMGN)

ImmunoGen, Inc. engages in the research and development of targeted therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies, and highly potent cell-killing agents. The company develops its products using its Targeted Antibody Payload (TAP) technology. Its product candidates include Trastuzumab emtansine (T-DM1), a Phase III clinical trial product for HER2+ breast cancer; lorvotuzumab mertansine (IMGN901), a Phase I clinical trial product, which targets CD56 found on small-cell lung cancer, Merkel cell carcinoma, multiple myeloma, ovarian cancers, carcinoid tumors, and other cancers of neuroendocrine origin; IMGN529, a pre-investigational new drug stage drug for CD37+ B-cell malignancies, such as non-Hodgkin's lymphoma; and IMGN853, a preclinical stage product for cancers that overexpress folate receptor 1, including ovarian cancer. The company?s earlier-stage compounds in development stage comprise SAR3419, a Phase I clinical trial product for CD19+ B-cell malignancies, including non-Hodgkin's lymphoma; SAR650984, a Phase I clinical trial product for CD38+ hematological malignancies; SAR566658, a phase one clinical trial product for DS6+ solid tumors; and BT-062, a Phase I product for multiple myeloma. It has collaboration agreements with Amgen, Inc.; Bayer Schering Pharma AG; Biogen Idec MA Inc.; Biotest AG; Genentech, Inc.; Novartis Institutes for BioMedical Research, Inc.; and sanofi-aventis U.S. LLC. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:
  • [By Sean Williams]

    High-risk, high-reward suggestions
    There's an undeniably large dollar amount being pledged to cancer research, but, even if a drug gains approval, that's no guarantee that the biotech or pharmaceutical company behind that drug will be a success. Some of the biggest gains (and losses) come from taking a leap of faith based on clinical data, or the approval of one or two drugs or devices within a pipeline. After that, it's all up to the drug or devices' effectiveness, its pricing, and the success of the marketing teams promoting the drug or device. Here are a few high-risk, high-reward names you should be keeping your eye on.

    Exelixis (NASDAQ: EXEL  ) : In November Exelixis had its first drug, known as Cometriq, approved by the Food and Drug Administration to treat metastatic medullary thyroid cancer. Although the market for this disease is pretty small -- somewhere between 500 and 700 people in the U.S. -- the near-tripling in progression-free survival, or PFS, in trials would indicate to me a strong likelihood that it could translate to success in other cancer types. In mid-stage prostate cancer trials, for instance, Cometriq was found to be particularly effective in dealing with bone metastases as a second or third-line treatment. We won't get any additional data until next year on Cometriq, but positive data on the prostate cancer front could be enough to double its share price if the PFS, compared to the placebo, is notably strong. ImmunoGen (NASDAQ: IMGN  ) : In February, Roche�and ImmunoGen received approval for Kadcyla as a secondary treatment for HER2-positive breast cancer. This is ImmunoGen's first drug approval, and it gives the company a chance to showcase what I feel is one of the future pathways of fighting cancer -- its targeted-antibody payload, or TAP, technology. ImmunoGen's TAP technology works by attaching a toxin -- in this case Roche's Herceptin -- to an antibody, and teaching that antibody to release the to
  • [By RichardCox]

    While it is important to seek out well-established companies with a proven product line, it should be remembered that it is still possible to find long-term opportunities in companies that are still in the clinical stage. In these cases, risk can be reduced by identifying those companies with a diversified set of drug innovations. So, when smaller companies are limited in the types of diseases and treatments, there is generally less protection from investment risk. One example of a smaller company with strong product positioning is ImmunoGen (IMGN).

Top 5 Information Technology Stocks To Watch Right Now: Bitcoin Collect Inc (BTCC)

Bitcoin Collect Inc, formerly SolPower, Corp., incorporated on July 22, 1996, offers software solutions for the healthcare industry addressing problems with the system involving billing, collections and the lack of adequate medical insurance. The company�� primary product is a software System called MedCare Collect. In July 2014, the Company acquired Good Vibrations Shoes.

Medcare Collect utilizes the technology in electronic banking and transaction submission allowing healthcare professionals to accept clients who may not have adequate health insurance with an almost negligible risk of the patient defaulting. MedCare Collect is revolutionizing medical billing by allowing doctors to take on patients they would otherwise have to turn away, while adding much needed revenue to their bottom line.

Advisors' Opinion:
  • [By Iampat]

    Square 1 Financial (SQBK) and Bitcoin (BTCC) have sort of touched on the accommodations of having a versatile wallet, and it's without a doubt a corner that I think is still in the early phases of its reception bend. Hence, when I discovered that Facebook was concentrating on it, I loved the thought.

Top 5 Information Technology Stocks To Watch Right Now: Snap-On Incorporated(SNA)

Snap-on Incorporated provides tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products include hand tools, such as wrenches, screwdrivers, sockets, pliers, ratchets, saws and cutting tools, pruning tools, and torque measuring instruments; power tools, including pneumatic, hydraulic, cordless, and corded tools; and tool storage products comprising tool chests, roll cabinets, and tool control systems. The company?s diagnostics and repair information products include handheld and PC-based diagnostics products, service and repair information products, diagnostic software solutions, electronic parts catalogs, business management systems, business services, point-of-sale systems, integrated systems for vehicle service shops, original equipment manufacturer purchasing facilitation services, and warranty management systems and analytics to manage and track performance. Snap-on Incorporated?s equipment products comprise solutions for the diagnosis and service of automotive and industrial equipment, such as wheel alignment, collision repair, air conditioning service, brake service, fluid exchange, transmission troubleshooting, and safety testing equipment, as well as wheel balancers, tire changers, vehicle lifts, test lane systems, battery chargers, and hoists. The company also provides financial services, including business loans and vehicle leases to franchisees; loans to the franchisees? customers; and loans to its industrial and other customers for the purchase of tools, equipment, and diagnostics products. Snap-on Incorporated sells its products and services through mobile vans, franchisees, company-direct sales, distributors, and the Internet in approximately 130 countries, including the United States, the United Kingdom, Canada, Germany, Australia, France, Japan, Spain, Italy, Sweden, the Netherlands, Argentina, China, and Brazil. Snap-on Incorporated was founded in 1920 and is based in Kenosh a, Wisconsin.

Advisors' Opinion:
  • [By Shauna O'Brien]

    Snap-on Incorporated (SNA) announced on Friday that it has agreed to acquire all of the assets of Pro-Cut International for $45 million.

    Snap-on will acquire Pro-Cut for $45 million in cash. Pro-Cut is a manufacturer and designed of on-car brake equipment. The company’s sales were approximately $25 million in 2013.

    Snap-On’s CEO and Chairman Nick Pinchuk commented: “Pro-Cut’s advanced brake servicing product line enhances and increases Snap-on’s offering of productivity solutions for vehicle repair facilities, including independent shops, national service chains and OEM dealerships.”

    “We believe Pro-Cut will be an important addition to our Repair Systems & Information Group and will help us move further along our coherent growth runway of expanding with repair shop owners and managers. We look forward to welcoming Pro-Cut associates to the Snap-on family,” Pinchuk added.

    SNA Dividend Snapshot

    As of Market Close on May 29, 2014

    Click here to see the complete history of SNA dividends.

    Snap-on shares were mostly flat during pre-market trading Friday. The stock is up 6.83% YTD.

  • [By Matt Thalman]

    Another player that operates heavily within this industry, but in a slightly different fashion, announced earnings today. Shares of tool company�Snap-On (NYSE: SNA  ) �rose 7.76% today after beating estimates on both the top and bottom lines. Revenue came in at $797.5 million for the quarter, a 5.9% increase from last year and higher than the $779.5 million analysts were looking for. Earnings per share hit $1.60, again higher than the $1.56 that was expected. One of the areas that management would like to focus on moving forward is expanding its vehicle repair garage, which again would make sense given the average age of vehicles on the road today.�

No comments:

Post a Comment